B
Beam Therapeutics
BEAM · NASDAQ · Healthcare
$27.48
+$0.23 (+0.84%) today
Loading live data...
Market Cap
$2.84B
24h Volume
$25.4M
P/E Ratio
-7.1
52w High
$37.92
52w Low
$16.01
Est. AI Revenue
12%
Loading chart data...
7-Day Sparkline (Static)
About Beam Therapeutics
Base editing biotechnology company using AI to develop precision genetic medicines with single-nucleotide changes.
CEO: John Evans
Founded: 2017
HQ: Cambridge, Massachusetts
Employees: 540
Performance
24 Hours+0.84%
7 Days+7.68%
30 Days-23.28%
1 Year+53.86%